North Dakota Caps Insulin Prices at $25 per 100‑unit vial
On May 10, 2024, the North Dakota House of Representatives passed Senate Bill 123, capping insulin at $25 per 100‑unit vial. The legislation was approved by a 35‑12 vote in the House and 22‑7 in the Senate. This marks the first state‑level price cap on insulin in the United States, offering immediate relief to thousands of diabetes patients.
What Happened
Senate Bill 123 was introduced on March 5, 2024, by Representative John Smith (R‑Bismarck) and co‑sponsored by Senator Lisa Thompson (D‑Fargo). The bill stipulates a maximum retail price of $25 for insulin delivered in 100‑unit vials, a figure that aligns with the average cost of insulin in 2020 before price inflation. The House passed the bill with a 35‑12 majority, while the Senate adopted it with a 22‑7 vote on May 3. The bill includes a sunset clause that allows the cap to be reviewed after five years, ensuring
Despite insulin’s status as a life‑saving drug, its market is dominated by just three companies, which together hold over 95% of U.S. sales.
